Compare WYETH LTD with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PFIZER - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PFIZER WYETH LTD/
PFIZER
 
P/E (TTM) x 27.7 36.2 76.6% View Chart
P/BV x 5.3 6.1 87.5% View Chart
Dividend Yield % 1.3 0.6 227.8%  

Financials

 WYETH LTD   PFIZER
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PFIZER
Mar-19
WYETH LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0443,840 27.2%   
Low Rs8182,080 39.3%   
Sales per share (Unadj.) Rs298.6455.0 65.6%  
Earnings per share (Unadj.) Rs57.293.8 61.0%  
Cash flow per share (Unadj.) Rs58.4109.4 53.4%  
Dividends per share (Unadj.) Rs17.0022.50 75.6%  
Dividend yield (eoy) %1.80.8 240.2%  
Book value per share (Unadj.) Rs249.5658.2 37.9%  
Shares outstanding (eoy) m22.7245.75 49.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.16.5 47.9%   
Avg P/E ratio x16.331.6 51.5%  
P/CF ratio (eoy) x15.927.1 58.9%  
Price / Book Value ratio x3.74.5 83.0%  
Dividend payout %29.724.0 123.8%   
Avg Mkt Cap Rs m21,157135,420 15.6%   
No. of employees `0000.52.6 18.7%   
Total wages/salary Rs m4003,238 12.4%   
Avg. sales/employee Rs Th13,787.47,911.4 174.3%   
Avg. wages/employee Rs Th813.01,230.9 66.1%   
Avg. net profit/employee Rs Th2,643.31,630.7 162.1%   
INCOME DATA
Net Sales Rs m6,78320,815 32.6%  
Other income Rs m3531,674 21.1%   
Total revenues Rs m7,13622,489 31.7%   
Gross profit Rs m1,6175,712 28.3%  
Depreciation Rs m27714 3.7%   
Interest Rs m673 7.5%   
Profit before tax Rs m1,9386,599 29.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6322,309 27.4%   
Profit after tax Rs m1,3014,291 30.3%  
Gross profit margin %23.827.4 86.9%  
Effective tax rate %32.635.0 93.3%   
Net profit margin %19.220.6 93.0%  
BALANCE SHEET DATA
Current assets Rs m6,98427,167 25.7%   
Current liabilities Rs m2,0568,917 23.1%   
Net working cap to sales %72.687.7 82.9%  
Current ratio x3.43.0 111.5%  
Inventory Days Days9968 146.4%  
Debtors Days Days2430 79.5%  
Net fixed assets Rs m2448,862 2.8%   
Share capital Rs m227458 49.7%   
"Free" reserves Rs m5,44129,656 18.3%   
Net worth Rs m5,66830,113 18.8%   
Long term debt Rs m2525 100.0%   
Total assets Rs m7,90139,400 20.1%  
Interest coverage x353.391.5 386.1%   
Debt to equity ratio x00 531.3%  
Sales to assets ratio x0.90.5 162.5%   
Return on assets %16.511.1 149.3%  
Return on equity %22.914.2 161.0%  
Return on capital %34.022.1 153.8%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m15428 3.5%   
Fx outflow Rs m2,677786 340.4%   
Net fx Rs m-2,662-358 743.4%   
CASH FLOW
From Operations Rs m923978 94.4%  
From Investments Rs m317351 90.2%  
From Financial Activity Rs m-481-1,099 43.8%  
Net Cashflow Rs m759231 328.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 63.9 80.0%  
Indian inst/Mut Fund % 11.3 7.5 150.7%  
FIIs % 7.2 4.9 146.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 23.7 128.3%  
Shareholders   21,978 85,207 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   FULFORD INDIA  SUVEN LIFESCIENCES  STERLING BIOTECH  WOCKHARDT  VENUS REMEDIES  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 202 Points Lower; Oil & Gas and Power Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day on a negative note. At the closing bell, the BSE Sensex stood lower by 202 points.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

More Views on News

Most Popular

Buy this 'Crorepati Stock' and You Could End Up Stinking Rich(Profit Hunter)

Feb 5, 2020

I'm talking about an individual small cap stock that could go up so many times that they make their investors stinking rich in the process. You definitely want to know more...

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Will Your Trade Go Up or Down Today?(Fast Profits Daily)

Feb 5, 2020

How you can find out which way your trade is likely to move on any given trading day.

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

No Change in My Long-Term View on the Rebirth of India Stocks(The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS